老年重症心力衰竭患者ICU诊断及治疗效果观察

Observation of ICU Diagnosis and Therapeutic Effect in Elderly Patients with Severe Heart Failure

目的观察老年重症心力衰竭患者重症监护室(ICU)诊断及治疗效果。方法选取2017年12月至2019年1月云南省普洱市景谷傣族彝族自治县人民医院ICU科室收治的96例老年重症心力衰竭患者为研究对象,分为A、B组,各48例。两组患者均接受心力衰竭常规治疗,A组另采用美洛托尔联合厄贝沙坦氢氯噻嗪治疗。观察两组治疗后效果。结果治疗后,A组治疗总有效率高于B组,并发症发生率低于B组,A组心率、B型尿钠肽低于B组,血尿酸高于B组(P<0.05);A组左心室射血分数高于B组和同组治疗前,左心室舒张末期内径及心脏NYHA分级低于B组和同组治疗前(P<0.05)。结论ICU老年重症心力衰竭患者在常规治疗中给予美洛托尔联合厄贝沙坦氢氯噻嗪治疗可取得满意疗效。

Objective To observe the diagnosis and treatment of intensive care unit(ICU)in elderly patients with severe heart failure.Methods From December 2017 to January 2019,96 elderly patients with severe heart failure admitted to ICU Department of Jinggu Dai and Yi Autonomous County People's Hospital of Puer City,Yunnan Province were selected as the study subjects.They were divided into group A and group B,48 cases in each group.Both groups received routine treatment of heart failure,while group A was treated with melatol combined with irbesartan hydrochlorothiazide,and the effect was observed and compared between groups after treatment.Results The total effective rate of group A was higher than that of group B.The complication rate was lower than that of group B.The heart rate and type B urinary peptide were lower in group A than in group B,and blood uric acid was higher than group B(P<0.05).After treatment,the left ventricular ejection fraction of group A was higher than that of group B and the same group before treatment.The left ventricular end-diastolic diameter and heart NYHA grade were lower than those of group B and the same group before treatment(P<0.05).Conclusion ICU patients with severe heart failure in the conventional treatment of metoprol combined with irbesartan hydrochlorothiazide can achieve satisfactory results,can be used as the clinical treatment of choice.